Skip to content
Recall Observatory FDA recall evidence

Drug product

Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3509-04 carton, NDC 0591-3509-54 pouch

D-0473-2026

March 19, 2026

Class II

Product summary

Firm
Teva Pharmaceuticals USA, Inc
Event
Event 98614
Status
Ongoing
Classification
Class II
Quantity
62,136 Cartons
Official record key
drug-enforcement:D-0473-2026

Official wording

Reason: CGMP Deviations: use of an unapproved raw material

Code information: Lot: 100060002, Exp.: 07/2026; 100066802, Exp.: 05/2027

Distribution pattern: Within U.S

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations